Mass-market home prices expected to hit bottom in mid-2016

Policy will be eased after May.

Mass-market home prices are expected to continue their decline in coming quarters and hit bottom by mid-2016, a report by Barclays said.

Barclays noted that mass market prices to fall another 10% by mid-2016 as mortgage rates rise.

“We expect prices of mass market projects to continue to trend downwards due to the large supply scheduled to come on stream between 2014 and 2018. However, we expect new supply completions to dip beyond 2018 due to the tight Government Land Sales policy since 1H12 and the low level of developer sales since the Total Debt Servicing Ratio (TDSR) policy was introduced in June 2013. We see the likelihood of a reprieve from the unwinding of property tightening measures happening after the general election, which has to take place by May 2016,” the report noted.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare